[Federal Register: February 26, 2009 (Volume 74, Number 37)]
[Notices]               
[Page 8811]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26fe09-70]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division

 
Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Industrial Macromolecular Crystallography 
Association

    Notice is hereby given that, on January 16, 2009, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act'') Industrial Macromolecular 
Crystallography Association (``IMCA'') has filed written notifications 
simultaneously with the Attorney General and the Federal Trade 
Commission disclosing changes in its membership. The notifications were 
filed for the purpose of extending the Act's provisions limiting the 
recovery of antitrust plaintiffs to actual damages under specified 
circumstances. Specifically, SmithKline Beecham Corporation, operating 
as Glaxo SmithKline, Philadelphia, PA; and Pfizer Global Research and 
Development, Groton, CT have withdrawn as parties to this venture.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and IMCA intends to file additional 
written notifications disclosing all changes in membership.
    On October 23, 1990, IMCA filed its original notification pursuant 
to Section 6(a) of the Act. The Department of Justice published a 
notice in the Federal Register pursuant to Section 6(b) of the Act on 
December 3, 1990 (55 FR 49952).
    The last notification was filed with the Department on August 21, 
2007. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on November 7, 2007 (72 FR 62865).

Patricia A. Brink,
Deputy Director of Operations, Antitrust Division.
[FR Doc. E9-4018 Filed 2-25-09; 8:45 am]

BILLING CODE 4410-11-M